Phenytoin for the prevention of motion sickness

Medical Journal of Australia

Volumn 178, Issue 11, 2003, Pages 575-576

  Albert, Edi G ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN; PLACEBO;

CLINICAL TRIAL; COGNITION; DIVER; DRUG BLOOD LEVEL; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; INTERNET; LOW DRUG DOSE; MEDICAL LITERATURE; MOTION SICKNESS; PUBLICATION; SAILOR; SHORT SURVEY; SPORT; TABLET; VERTIGO; VOMITING;

EID: 0038143372     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05362.x     Document Type: Short Survey

References (6)

1. Chelan W, Kabrisky M, Hatsell C, et al. Use of phenytoin in the prevention of motion sickness. Aviat Space Environ Med 1990; 61: 1022-1025.
2. Woodard D, Knox G, Myers KJ, et al. Phenytoin as a countermeasure for motion sickness in NASA maritime operations. Aviat Space Environ Med 1993; 64: 363-366.
3. Knox GW, Woodard D, Chelan W, et al. Phenytoin for motion sickness: Clinical evaluation. Laryngoscope 1994; 104: 935-939.
4. Chelan W, Ahmed N, Kabrisky M, Roger S. Computerized task battery assessment of cognitive and performance effects of acute phenytoin motion sickness therapy. Aviat Space Environ Med 1993; 64: 201-205.
5. Stern RM, Uijtdehaage SH, Muth ER, Koch KL. Effects of phenytoin on vection-induced motion sickness and gastric myoelectric activity. Aviat Space Environ Med 1994; 65: 518-521.
6. Diving Medicine Online. Available at: http://www.scuba-doc.com/moresea.htm (accessed Mar 2003).